Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Comparative study on infection rate of different adeno-associated virus for knee joint cartilage in mice].

Hu JM, Chen Q, Zhou JY, Wu JT, Yu H, Fu FD, Ruan HF, Xiao LW, Wu CL, Tong PJ.

Zhongguo Gu Shang. 2019 Aug 25;32(8):750-755. doi: 10.3969/j.issn.1003-0034.2019.08.015. Chinese.

PMID:
31533389
2.

Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees.

Payne KA, Lee HH, Haleem AM, Martins C, Yuan Z, Qiao C, Xiao X, Chu CR.

Osteoarthritis Cartilage. 2011 Aug;19(8):1058-65. doi: 10.1016/j.joca.2011.04.009. Epub 2011 Apr 28.

3.

Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.

Balaji S, King A, Dhamija Y, Le LD, Shaaban AF, Crombleholme TM, Keswani SG.

J Surg Res. 2013 Sep;184(1):691-8. doi: 10.1016/j.jss.2013.03.051. Epub 2013 Apr 3.

4.

[EXPERIMENTAL STUDY ON LENTIVIRUS-MEDIATED MULTI-GENES CO-TRANSFECTION IN BONE MARROW MESENCHYMAL STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS IN CYNOMOLGUS MONKEY].

Zhang Z, Li X, Wang Y, Cui Z, Chen Z, Zhang H.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2016 Sep 8;30(9):1153-1159. doi: 10.7507/1002-1892.20160235. Chinese.

PMID:
29786374
5.

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Li W, Kong F, Li X, Dai X, Liu X, Zheng Q, Wu R, Zhou X, Lü F, Chang B, Li Q, Hauswirth WW, Qu J, Pang JJ.

Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.

6.

Gene transfer into skeletal muscle using novel AAV serotypes.

Louboutin JP, Wang L, Wilson JM.

J Gene Med. 2005 Apr;7(4):442-51.

PMID:
15517544
7.

Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

Yang GS, Schmidt M, Yan Z, Lindbloom JD, Harding TC, Donahue BA, Engelhardt JF, Kotin R, Davidson BL.

J Virol. 2002 Aug;76(15):7651-60.

8.

Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants.

Benskey MJ, Kuhn NC, Galligan JJ, Garcia J, Boye SE, Hauswirth WW, Mueller C, Boye SL, Manfredsson FP.

Mol Ther. 2015 Mar;23(3):488-500. doi: 10.1038/mt.2015.7. Epub 2015 Jan 16.

9.

Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.

Li P, Boenzli E, Hofmann-Lehmann R, Helfer-Hungerbuehler AK.

PLoS One. 2019 Mar 21;14(3):e0212811. doi: 10.1371/journal.pone.0212811. eCollection 2019.

10.

Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

Sun J, Hakobyan N, Valentino LA, Feldman BL, Samulski RJ, Monahan PE.

Blood. 2008 Dec 1;112(12):4532-41. doi: 10.1182/blood-2008-01-131417. Epub 2008 Aug 20.

11.

Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Qi YF, Li QH, Shenoy V, Zingler M, Jun JY, Verma A, Katovich MJ, Raizada MK.

Clin Exp Pharmacol Physiol. 2013 Jan;40(1):53-5. doi: 10.1111/1440-1681.12037.

12.

Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse.

Kong F, Li W, Li X, Zheng Q, Dai X, Zhou X, Boye SL, Hauswirth WW, Qu J, Pang JJ.

Exp Eye Res. 2010 May;90(5):546-54. doi: 10.1016/j.exer.2010.01.011. Epub 2010 Feb 4.

13.

Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.

Chai Z, Sun J, Rigsbee KM, Wang M, Samulski RJ, Li C.

J Control Release. 2017 Sep 28;262:348-356. doi: 10.1016/j.jconrel.2017.08.005. Epub 2017 Aug 5.

14.

[Efficiency of three adeno-associated viruses for transfecting enhanced green fluorescent protein in Tibet minipig fetal fibroblasts].

Huang W, Mao Y, Liu W, Tang H, Jie F, Li H, Gu W.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):857-61. Chinese.

PMID:
22699070
15.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9. Epub 2002 Aug 21.

16.

Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

Mol Vis. 2008 Sep 24;14:1760-9.

17.

Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer.

Lei B, Zhang K, Yue Y, Ghosh A, Duan D.

Mol Vis. 2009 Jul 17;15:1374-82.

18.

Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo.

Mao Y, Wang X, Yan R, Hu W, Li A, Wang S, Li H.

BMC Biotechnol. 2016 Jan 5;16:1. doi: 10.1186/s12896-015-0230-0.

19.

Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice.

Takahashi H, Kato K, Miyake K, Hirai Y, Yoshino S, Shimada T.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4):455-61.

PMID:
16095112
20.

Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.

Xin KQ, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, Oomura K, Kojima Y, Ichino M, Klinman D, Ozawa K, Okuda K.

J Virol. 2006 Dec;80(24):11899-910. Epub 2006 Sep 27.

Supplemental Content

Support Center